HELD Stock Overview
Hellenic Dynamics Plc engages in the cultivation and supply of tetrahydrocannabinol (THC) dominant strains of medical cannabis flowers in Europe.
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 0/6 |
| Dividends | 0/6 |
Hellenic Dynamics Plc Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | UK£0.024 |
| 52 Week High | UK£0.22 |
| 52 Week Low | UK£0.022 |
| Beta | 0 |
| 1 Month Change | -5.88% |
| 3 Month Change | -39.24% |
| 1 Year Change | -82.86% |
| 3 Year Change | -90.94% |
| 5 Year Change | -98.52% |
| Change since IPO | -99.81% |
Recent News & Updates
Recent updates
Shareholder Returns
| HELD | GB Pharmaceuticals | GB Market | |
|---|---|---|---|
| 7D | -18.6% | 6.3% | 1.1% |
| 1Y | -82.9% | 5.7% | 1.9% |
Return vs Industry: HELD underperformed the UK Pharmaceuticals industry which returned 5.4% over the past year.
Return vs Market: HELD underperformed the UK Market which returned 2.3% over the past year.
Price Volatility
| HELD volatility | |
|---|---|
| HELD Average Weekly Movement | 11.0% |
| Pharmaceuticals Industry Average Movement | 7.8% |
| Market Average Movement | 4.8% |
| 10% most volatile stocks in GB Market | 11.5% |
| 10% least volatile stocks in GB Market | 2.7% |
Stable Share Price: HELD's share price has been volatile over the past 3 months.
Volatility Over Time: HELD's weekly volatility (11%) has been stable over the past year, but is still higher than 75% of UK stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2007 | n/a | Davinder Rai | www.hellenicdynamics.com |
Hellenic Dynamics Plc engages in the cultivation and supply of tetrahydrocannabinol (THC) dominant strains of medical cannabis flowers in Europe. It offers medical cannabis product. The company was incorporated in 2007 and is based in London, the United Kingdom.
Hellenic Dynamics Plc Fundamentals Summary
| HELD fundamental statistics | |
|---|---|
| Market cap | UK£3.16m |
| Earnings (TTM) | UK£0 |
| Revenue (TTM) | n/a |
n/a
P/E Ration/a
P/S RatioIs HELD overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| HELD income statement (TTM) | |
|---|---|
| Revenue | UK£0 |
| Cost of Revenue | UK£0 |
| Gross Profit | UK£0 |
| Other Expenses | UK£0 |
| Earnings | UK£0 |
Last Reported Earnings
n/a
Next Earnings Date
n/a
| Earnings per share (EPS) | 0 |
| Gross Margin | 0.00% |
| Net Profit Margin | 0.00% |
| Debt/Equity Ratio | 0.0% |
How did HELD perform over the long term?
See historical performance and comparison